Please wait.'

Page is loading'


Home  > Raw materials & technologies  > Technologies  > A promising approach for controlled porosi...

Thursday, 09 July 2020
pdf
Raw materials & technologies, Technologies

A promising approach for controlled porosity osmotic pump tablets of Captopril

Thursday, 23 April 2020

Chemists have investigated a leachable pegylated cellulose acetate complex as a promising approach for controlled porosity osmotic pump tablets of Captopril.

A leachable pegylated cellulose acetate complex as a promising approach for controlled porosity osmotic pump tablets of Captopril has been investigated. Image source: OpenClipArtVectors - Pixabay (symbol image).
A leachable pegylated cellulose acetate complex as a promising approach for controlled porosity osmotic pump tablets of Captopril has been investig...

The aim of the present study was to develop pegylated cellulose acetate coating layer having leachable membrane created by controlled porosity osmotic pump (CPOP) technique. Already optimised core tablets of Captopril were used for the application of CPOP. In Box–Behnken design, cellulose acetate, polyethylene glycol, and sorbitol were used as variables and %Captopril release as a response for the coating process.

Formulations were characterised by weight gain, thickness of leachable membrane, content uniformity, drug release, pH, dissolution medium osmolality effect, FTIR, and stability analysis for the optimisation purpose. Optimised formulation was within the pharmacopoeial limits. Observed weight gain was 4.38–6.97%, and thickness of leachable membrane was 1.24–1.47 mm. Content uniformity was found to be 91.65–99.61%. Phosphate buffer of pH 6.8 showed 86.22–92.79% drug release and the first-order release pattern. pH-independent but osmolality-dependent drug release was observed.

Prepared CPOP tablets can be used for the controlled release of Captopril

No incompatibility between the ingredients of prepared dosage form was observed in FTIR analysis. Accelerated stability study for 6 months showed no significant change in the prepared dosage form.

Conclusively, prepared CPOP tablets can be used for the controlled release of Captopril in hypertensive patients to maintain the desired drug concentration within the body for required time period.

The study has been published in Journal of Coatings Technology and Research volume 17 (2020).

Image source: Pixabay.

top of page
Comments (0)
Add Comment

Post comment

You are not logged in

register